Abstract
In response to the COVID-19 pandemic, many higher educational institutions moved their courses on-line in hopes of slowing disease spread. The advent of multiple highly-effective vaccines offers the promise of a return to “normal” in-person operations, but it is not clear if – or for how long – campuses should employ non-pharmaceutical interventions such as requiring masks or capping the size of in-person courses. In this study, we develop and fine-tune a model of COVID-19 spread to UC Merced’s student and faculty population. We perform a global sensitivity analysis to consider how both pharmaceutical and non-pharmaceutical interventions impact disease spread. Our work reveals that vaccines alone may not be sufficient to eradicate disease dynamics and that significant contact with an infected surrounding community will maintain cases on-campus. Our work provides a foundation for higher-education planning allowing campuses to balance the benefits of in-person instruction with the ability to quarantine/isolate infected individuals.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The work presented in this manuscript is based upon work supported by the National Science Foundation (DMS 1840265 and ACI 1429783), the Joint Initiative to Support Research at the Interface of the Biological and Mathematical Sciences between the National Science Foundation Division of Mathematical Sciences (NSF DMS) and National Institutes of Health National Institute of General Medical Sciences (NIH NIGMS) (Grant No. R01 GM126548), and UC Merced COVID-19 Seed Grant.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Open-source code for the global sensitivity analysis and contact matrices can be found at https://github.com/FS-CodeBase/gsa_of_covid19_transmission_on_a_university_campus.
